Singapore markets closed

Relmada Therapeutics, Inc. (RLMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6800-0.0400 (-1.08%)
At close: 04:00PM EDT
3.6800 0.00 (0.00%)
After hours: 05:06PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. Estimate-0.85-0.88-3.06-2.36
Low estimate-0.92-1-3.8-4.12
High estimate-0.75-0.75-2.61-1.6
Year ago EPS-0.87-0.84-3.28-3.06
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5555
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.89-0.9-0.91-0.83
Actual EPS-0.87-0.84-0.73-0.84
Difference0.020.060.18-0.01
Surprise %2.20%6.70%19.80%-1.20%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.85-0.88-3.06-2.36
7 days ago-0.85-0.88-3.06-2.36
30 days ago-0.85-0.88-3.06-2.36
60 days ago-0.97-0.78-2.64-2.61
90 days ago-0.97-0.78-2.64-2.61
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRLMDIndustrySector(s)S&P 500
Current qtr.2.30%N/AN/AN/A
Next qtr.-4.80%N/AN/AN/A
Current year6.70%N/AN/AN/A
Next year22.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A